News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
206 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26097)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (304)
2 (302)
3 (234)
4 (222)
5 (108)
6 (3)
7 (15)
8 (212)
9 (260)
10 (221)
11 (237)
12 (101)
13 (4)
14 (12)
15 (202)
16 (227)
17 (235)
18 (206)
19 (47)
20 (2)
21 (1)
22 (157)
23 (253)
24 (233)
25 (241)
26 (126)
27 (6)
28 (11)
29 (245)
30 (295)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
Pharma Biotech and Nutrition Businesses Continue to Drive Lonza Performance in Q1 2019
All investments in healthcare businesses progressing as planned to further accelerate growth
April 18, 2019
·
10 min read
Unique data-driven tool shows diabetes not a barrier to joint replacement surgery
Based on data from 40,000 patients, the ORA risk assessment tool is designed to support orthopaedic surgeons as they make decisions about joint replacement surgery.
April 18, 2019
·
3 min read
Deals
Recipharm publishes Annual Report 2018
The report summarises the business and highlights for 2018 and gives insights into the company’s strategy.
April 18, 2019
·
1 min read
Novotech CRO strengthens South Korean Clinical Capabilities partnering with 2 Major Hospitals
Ulsan University Hospital (UHH) and Seoul National University Hospital (SNUH), Hepatology Division have joined the Novotech CRO partnership program
April 18, 2019
·
2 min read
Business
Talaris Rebrands and Grabs $100 Million, New CEO and Leadership Team
Talaris, most recently known as Regenerex, will use the funding to launch a Phase III registration trial of its allogenic cell therapy in living donor kidney transplant recipients.
April 18, 2019
·
3 min read
·
Alex Keown
Business
GSK Makes Cuts as It Implements New R&D Focus on Oncology, Immunology and Genetics
Since GSK initiated this new focus, the company has made several key moves to support the plan, including the December 2018 acquisition of Tesaro Oncology.
April 18, 2019
·
3 min read
·
Alex Keown
Job Trends
Life Sciences Industry Threatened by Skills Shortage
There is something of a recurring theme among the life science, healthcare and biopharma industries: shortage of skilled employees will lead to a decrease in innovation.
April 18, 2019
·
5 min read
·
Mark Terry
Business
Microbix Announces Management Changes
Ken Hughes Appointed COO, Kathryn Froh Retiring
April 18, 2019
·
4 min read
Business
NetCents Technology Begins Processing for First Charity Partner: HS Aware
NetCents Technology Inc. is pleased to announce that it has begun processing cryptocurrency transactions for its first charity partner, HS Aware.
April 18, 2019
·
4 min read
Genetown
Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development
Financing will support Phase 3 trial of FCR001 for living donor kidney transplant patients and additional Phase 2 studies in high-need indications
April 18, 2019
·
6 min read
Previous
3 of 21
Next